Concepedia

Publication | Open Access

Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects

86

Citations

38

References

2015

Year

Abstract

Merck & Co. Inc., Kenilworth, New Jersey, USA. Additional support for instrumentation was obtained from the National Center for Advancing Translational Sciences (UL1TR000003 and UL1TR000040).

References

YearCitations

Page 1